REGN

#254
Regeneron Pharmaceuticals, Inc. - Common Stock
619.4 2 USD
-0.34%
부문: 헬스케어
베이스: USD
수익 통화: USD
일일 변동 비율
617.80
624.47
년간 변동
476.48
821.11
일일 변동
-0.34%
월간 변동
-10.63%
6달 변화
-20.17%
년간 변동율
+20.04%
이전 종가
621.5 2
Open
620.1 1
저가
617.8 0
High
624.4 7
양
685
전체 차트 열기 Full chart

Financials

개요 성명 통계 배당금
4분기 연간
  • Market Capitalization 64.94 B
  • Employee 15 K
  • Founded 1988
  • CEO Leonard Schleifer
  • Website www.regeneron.com
  • Headquarter New York, United States
  • FIGI BBG000C734W3
  • Industry 생명공학
총매출
순이익
주당 순이익(기본 EPS)
총부채
잉여 현금 흐름
현금 및 현금성 자산
주가수익비율
18.61
주가매출액비율
5.84

Regeneron Pharmaceuticals, Inc. - Common Stock

Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988. Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its present name; the company has since expanded operations into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a VEGF-trap.

뉴스